Gregory Gorgas
Chief Executive Officer bij ARTELO BIOSCIENCES, INC.
Vermogen: 30 260 $ op 31-03-2024
Profiel
Gregory D.
Gorgas is currently the President, CEO, CFO, Secretary & Treasurer at Artelo Biosciences, Inc. He is also a Director at Klotho Therapeutics, Inc. Previously, he was the Senior Director-Global & United States Marketing at Biogen, Inc. from 2006 to 2008.
From 2009 to 2011, he was the Managing Director at Theragence, Inc. He then became the Senior Vice President-Commercial at Mast Therapeutics, Inc. from 2011 to 2017.
He also served as the Senior Vice President-Commercial at Savara, Inc. He received his undergraduate degree from The California State University and his MBA from the University of Phoenix.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARTELO BIOSCIENCES INC
0.63% | 28-02-2024 | 20 446 ( 0.63% ) | 30 260 $ | 31-03-2024 |
Actieve functies van Gregory Gorgas
| Bedrijven | Functie | Begin |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Chief Executive Officer | 03-04-2017 |
Klotho Therapeutics, Inc.
 Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Klotho Therapeutics, Inc. operates as a biotechnology company. It develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease. The company was founded by James Plante in 2016 and is headquartered in San Diego, CA. | Director/Board Member | - |
Eerdere bekende functies van Gregory Gorgas
| Bedrijven | Functie | Einde |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-01-2017 |
| SAVARA INC. | Corporate Officer/Principal | 28-12-2016 |
Theragence, Inc.
 Theragence, Inc. Pharmaceuticals: MajorHealth Technology Theragence, Inc. provides pharmaceutical preparations. The private company is based in San Diego, CA. | Chief Executive Officer | 01-07-2011 |
| BIOGEN INC. | Sales & Marketing | 01-10-2008 |
Opleiding van Gregory Gorgas
| The California State University | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| ARTELO BIOSCIENCES, INC. | Health Technology |
| SAVARA INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Theragence, Inc. provides pharmaceutical preparations. The private company is based in San Diego, CA. | Health Technology |
Klotho Therapeutics, Inc.
Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Klotho Therapeutics, Inc. operates as a biotechnology company. It develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease. The company was founded by James Plante in 2016 and is headquartered in San Diego, CA. | Commercial Services |
